PDCO
38
2
CFG
52
-2
GRMN
68
-2
LMT
27
-2
NVDA
54
2
STX
52
2
EBAY
40
6
PEP
47
3
AMGN
47
8
SEE
45
-4
FOX
51
9
BEN
33
-5
STZ
50
7
EXPE
74
2
AAL
48
6
AME
62
3
GWW
64
-3
CMCSA
59
6
C
50
-4
VNO
52
-8
PDCO
38
2
CFG
52
-2
GRMN
68
-2
LMT
27
-2
NVDA
54
2
STX
52
2
EBAY
40
6
PEP
47
3
AMGN
47
8
SEE
45
-4
FOX
51
9
BEN
33
-5
STZ
50
7
EXPE
74
2
AAL
48
6
AME
62
3
GWW
64
-3
CMCSA
59
6
C
50
-4
VNO
52
-8
Financhill
Back

Cellectar Biosciences Vs. Marinus Pharmaceuticals Industry Stock Comparison

Sell
38

CLRB
Cellectar Biosciences

Last Price:
2.04
Seasonality Move:
-1.23%
Sell
31

MRNS
Marinus Pharmaceuticals

Last Price:
0.34
Seasonality Move:
12.73%
Sell
38
Cellectar Biosciences (CLRB) is a Sell

Is Cellectar Biosciences a Buy, Sell or Hold?

  • The current Cellectar Biosciences [CLRB] share price is $2.03. The Score for CLRB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • CLRB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Marinus Pharmaceuticals (MRNS) is a Sell

Is Marinus Pharmaceuticals a Buy, Sell or Hold?

  • The current Marinus Pharmaceuticals [MRNS] share price is $0.34. The Score for MRNS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • MRNS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CLRB Stock Price Chart

What is Cellectar Biosciences's stock price today?

  • The Cellectar Biosciences share price today is $2.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing slight selling pressure.

MRNS Stock Price Chart

What is Marinus Pharmaceuticals's stock price today?

  • The Marinus Pharmaceuticals share price today is $0.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRNS is experiencing buying pressure, which is a positive indicator for future bullish movement.

CLRB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 44.93 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.04 - 2.14) Sell
Bollinger Bands (100): (1.93 - 2.57) Sell

MRNS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.37 Sell
Relative Strength Index (14 RSI): 23.83 Sell
Chaikin Money Flow: 1451987 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.64 - 1.96) Sell
Bollinger Bands (100): (1 - 1.72) Sell

CLRB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.05 Sell
20-day SMA: 2.07 Sell
50-day SMA: 2.09 Sell
200-day SMA: 2.87 Sell
8-day EMA: 2.05 Sell
20-day EMA: 2.06 Sell
50-day EMA: 2.12 Sell
200-day EMA: 2.51 Sell

MRNS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.33 Buy
20-day SMA: 1.19 Sell
50-day SMA: 1.41 Sell
200-day SMA: 3.73 Sell
8-day EMA: 0.52 Sell
20-day EMA: 0.96 Sell
50-day EMA: 1.29 Sell
200-day EMA: 3.12 Sell

Cellectar Biosciences Earnings Growth & CLRB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.08 per share, and an increase next year of $1.21 per share.

Marinus Pharmaceuticals Earnings Growth & MRNS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.62 per share, and an increase next year of $1.17 per share.

Cellectar Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Marinus Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):